Navigation Links
BioInformatics, LLC New Market Report - Genomics Technologies
Date:1/6/2011

ARLINGTON, Va., Jan. 6, 2011 /PRNewswire/ -- BioInformatics, LLC announces the release of their newest market report:

Genomic Technologies:  Market Insights for Life Science Suppliers (#10-005)This report is for life science suppliers who want to respond in a timely fashion to the rapidly changing market for genomic analysis products. In this study, BioInformatics LLC quantifies and characterizes the market for genetic analysis including those products used for genome-wide association studies (GWAS), copy number variation (CNV) analysis, genotyping and techniques such as microarrays, sequencing and real-time PCR.

Survey respondents indicate planned lab expenditures by vendor.  The following suppliers were provided as some of the choices in the survey: Agilent TechnologiesAffymetrixBeckman CoulterBD BiosciencesBioneerBio-RadBioTroveCepheidEppendorfGE HealthcareHelicos BioscienceIdaho Technology, Inc.IlluminaLi-Cor BiosciencesLife TechnologiesLuminexQiagenRoche Applied ScienceSequenomStratageneTechne"In this study, we look at genetic analysis in current life science laboratories, the techniques and applications used, satisfaction and unmet needs with respect to current product offerings, budgets and predicted growth and future needs among life scientists," states Tamara Zemlo, Ph.D., MPH, Vice President of Advisory Services.  Dr. Zemlo adds that, "The information presented in this report will provide life science suppliers with information they can use to better meet their customers' needs as the field of genetic analysis continues to expand in new directions."

To learn more about these reports, a complimentary Executive Summary is available at

http://www.gene2drug.com/index.php?page=reports&id=211

ABOUT BIOINFORMATICS, LLC

BioInformatics, LLC is the premier research and advisory firm serving the life science industry.  By leveraging our professional social network of more than 50,000 life scientists, we have supported more than 300 companies and provided insights that lead to better business decisions.  Our assignments include assessing the size and attractiveness of markets, optimizing product configurations and pricing, validating corporate acquisitions, measuring customer loyalty, and evaluating brand strength and positioning.

For more information contact:Mary FollinManager, Marketing/SalesBioInformatics, LLC2111 Wilson Blvd., Suite 250Arlington, VA  22201703.778.3080 x13 (phone)m.follin@gene2drug.com

http://www.gene2drug.com/
'/>"/>

SOURCE BioInformatics, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. BioInformatics, LLC Offers Solutions for Optimizing Service and/or Maintenance Contracts
2. BioInformatics, LLC Studies Effective Strategies for Scientific Publishing in a Web 2.0 World
3. BioInformatics, LLC New Report -- The Market for Antibodies: Keys to Success for Commercial Suppliers, Vol. III
4. BioInformatics, LLC New Report - The Market Outlook for Research Products in FY2010
5. Concentric Medical(R) Announces Co-Marketing Agreement With InTouch Health(R) to Advance Acute Ischemic Stroke Care
6. XTL Biopharmaceuticals Receives Notice of Non-Compliance with Nasdaq Marketplace Rule Due to Changes in Board Composition
7. BMP Sunstone Receives Production License from the SFDA to Manufacture and Market Pediatric Multivitamin Granules in the PRC
8. Huifeng Bio-Pharmaceutical (HFGB) to Attend CPhI South America 2008 Pharmaceutical Conference; The First CPhI Conference to be held in the Emerging Market of Brazil
9. Oncothyreon announces receipt of notice of non-compliance with market value of listed securities standard for listing on The NASDAQ Global Market
10. Sonus Pharmaceuticals and OncoGenex Technologies complete business combination; OncoGenex Pharmaceuticals to commence trading on NASDAQ Capital Market today
11. PAREXEL Data Indicate U.S. Marketing Applications for New Molecular Entities Bounce Back
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 2016   Boston Biomedical , an industry ... to target cancer stemness pathways, announced that its ... Drug Designation from the U.S. Food and Drug ... including gastroesophageal junction (GEJ) cancer. Napabucasin is an ... cancer stemness pathways by targeting STAT3, and is ...
(Date:6/23/2016)... ... June 23, 2016 , ... Charm Sciences, ... microbial test has received AOAC Research Institute approval 061601. , “This is another ... year,” stated Bob Salter, Vice President of Regulatory and Industrial Affairs. “The Peel ...
(Date:6/23/2016)... ... , ... Supplyframe, the Industry Network for electronics hardware design ... Located in Pasadena, Calif., the Design Lab’s mission is to bring together inventors ... and brought to market. , The Design Lab is Supplyframe’s physical representation of ...
(Date:6/23/2016)... , June 23, 2016  Blueprint Bio, a company ... to the medical community, has closed its Series A ... Nunez . "We have received a commitment ... capital we need to meet our current goals," stated ... us the runway to complete validation on the current ...
Breaking Biology Technology:
(Date:4/28/2016)... , April 28, 2016 Infosys ... (NYSE: INFY ), and Samsung SDS, a global ... that will provide end customers with a more secure, fast ...      (Logo: http://photos.prnewswire.com/prnh/20130122/589162 ) , ... but it also plays a fundamental part in enabling and ...
(Date:4/19/2016)... 20, 2016 The new GEZE ... compact web-based "all-in-one" system solution for all door components. ... or the door interface with integration authorization management system, ... systems. The minimal dimensions of the access control and ... building installations offer considerable freedom of design with regard ...
(Date:4/13/2016)... , April 13, 2016  IMPOWER physicians supporting Medicaid ... setting a new clinical standard in telehealth thanks to ... leveraging the higi platform, IMPOWER patients can routinely track ... and body mass index, and, when they opt in, ... convenient visit to a local retail location at no ...
Breaking Biology News(10 mins):